Inoue, Hiroto
Ono, Akira
Kawabata, Takanori
Mamesaya, Nobuaki
Kawamura, Takahisa
Kobayashi, Haruki
Omori, Shota
Wakuda, Kazushige
Kenmotsu, Hirotsugu
Naito, Tateaki
Murakami, Haruyasu
Yasui, Kazuaki
Ogawa, Hirofumi
Onoe, Tsuyoshi
Endo, Masahiro
Harada, Hideyuki
Takahashi, Toshiaki
Article History
Received: 17 January 2020
Accepted: 25 February 2020
First Online: 3 March 2020
Change Date: 26 June 2020
Change Type: Correction
Change Details: Corrections are needed to the original version of this article. In Table 2, the “Odds ratio” of the variables “Lower lobe vs. Upper lobe” and “≥26 vs. <26” should be 2.250 instead of 2250 and 2.250 instead of 2.25.
Compliance with ethical standards
:
: H Inoue declares that he has no conflict of interest. A Ono received honoraria from AstraZeneca. T Kawabata declares that he has no conflict of interest. N mamesaya received honoraria from AstraZeneca. T Kawamura declares that he has no conflict of interest. H Kobayashi declares that he has no conflict of interest. S Omori received honoraria from AstraZeneca. K Wakuda received honoraria from AstraZeneca. H Kenmotsu received honoraria and research funding to our institution from AstraZeneca. T Naito declares that he has no conflict of interest. H Murakami received honoraria and research funding to our institution from AstraZeneca. K Yasui declares that he has no conflict of interest. H Ogawa declares that he has no conflict of interest. T Onoe declares that he has no conflict of interest. M Endo received honoraria from AstraZeneca. H Harada received honoraria from AstraZeneca. T Takahashi received honoraria and research funding to our institution from AstraZeneca.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional Review Board of Shizuoka Cancer Center (reference number: 30-J134–30–1-3) and with the 1964 Helsinki declaration and its later amendments or with comparable ethical standards.
: For this type of study, formal consent is not required.